By Peter A. McCullough, MD, MPH
A British High Court case filed by victims of blood clots caused by the AstraZeneca Oxford COVID-19 vaccine has the media buzzing over a company admission to a serious blood clotting condition called VITT or vaccine induced thrombocytopenic purpura.
Written by
By Peter A. McCullough, MD, MPH A British High Court case filed by victims of blood clots caused by the AstraZeneca Oxford COVID-19 vaccine has the media buzzing over a company admission to a serious blood clotting condition called VITT or vaccine induced thrombocytopenic purpura.
I would like to express my deepest admiration to every one of our information drop volunteers who, in all weathers, travelled the country with us. You are the unknown, unsung heroes of WakeUpéiRe. Your presence alone undoubtedly helped thousands of people.
